Rankin Elisabeth M 4

What Happened

• Elisabeth M. Rankin, reported as a "Member of a Group," acquired 20 shares of Hyster‑Yale on 2026-06-15 in a purchase transaction reported as a derivative acquisition. The reported price was $38.30 per share for a total reported value of $766. This was a purchase (a net buy), which retail investors often view as a more informative signal than routine sales.

Key Details

• Transaction date and price: 2026-06-15 — 20 shares at $38.30 per share (total $766).
• Transaction type: P = Purchase (reported as a derivative transaction on the Form 4).
• Shares owned after transaction: Not disclosed in the filing.
• Footnotes: None reported (F1–F4 = N/A).
• Filing timeliness: Report filed 2026-06-17 for the 2026-06-15 transaction — filed within the typical two-business-day Form 4 window (timely).

Context

• The Form 4 labels the acquisition as "Derivative," which may indicate the purchase involved a derivative instrument or was reported under derivative wording; the filing does not provide further detail.
• The insider is reported as a member of a group (not identified in this filing as an officer or director), so interpret accordingly — group-member trades can reflect coordinated holdings rather than an individual executive decision.
• No additional notes (10b5-1 plan, tax withholding, or cashless exercise) were disclosed.